Natasha B. Leighl

2 ta ish

Georgetown University

1. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

   Edward B. Garon, Naiyer A. Rizvi, Rina Hui +24

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.577441

2. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

   Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider +26

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.769170